Pancreatic Cancer Research

ResearcherMerrimack Pharmaceuticals (United States)No recent work listed

Eliel Bayever

Matched on OpenAlex author ID A5048957048.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2
Pancreatic cancer trials
1
Pancreatic cancer grants
0
Collaborators
4
Papers, trials and grants by year

2011: 1 trial · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers

Papers 2

  1. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, rand… Co-author DOI 10.1016/s0140-6736(15)00986-1↗
  2. Nanoliposomal irinotecan in metastatic pancreatic cancer - Authors' reply. Co-author DOI 10.1016/s0140-6736(16)30365-8↗

Trials 1

  1. Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer Study director NCT01494506↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Bruce Belanger · 1 shared paper, 2016
  2. Li-Tzong Chen · 1 shared paper, 2016
  3. Andrea Wang-Gillam · 1 shared paper, 2016
  4. Daniel D. Von Hoff · 1 shared paper, 2016

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.